Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

132
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
132
Pharmacovigilance01:19

Pharmacovigilance

1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

1.3K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

403
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
403
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

121
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
121
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

133
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
133

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical code embeddings from claims-based co-occurrences: a unified semantic space for ICD-10 diagnoses and ATC medications.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

Multicellular simulations with shape and volume constraints using optimal transport.

Science advances·2026
Same author

Impact on fertility according to treatment: analysis of French national medical database on uterine fibroid management (Myomectomy versus Embolization).

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways.

Cell chemical biology·2026
Same author

Evaluating the Role of Order and Time Information for Classifying Sequences of Healthcare Events Derived from Claims Data.

Studies in health technology and informatics·2026
Same author

A ginsenoside metabolite and its derivative target PRELID3B against lung cancer cells.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Sep 22, 2025

Microfluidic Imaging Flow Cytometry by Asymmetric-detection Time-stretch Optical Microscopy ATOM
07:19

Microfluidic Imaging Flow Cytometry by Asymmetric-detection Time-stretch Optical Microscopy ATOM

Published on: June 28, 2017

10.4K

Accelerating High-Dimensional Temporal Modelling Using Graphics Processing Units for Pharmacovigilance Signal

Pierre Sabatier1,2, Jean Feydy2, Anne-Sophie Jannot1

  • 1AP-HP.Centre, Université de Paris, Paris, France.

Studies in Health Technology and Informatics
|May 25, 2022
PubMed
Summary

We optimized the Weighted Cumulative Exposure (WCE) model for analyzing adverse drug reactions using Graphics Processing Units (GPUs). This GPU acceleration significantly speeds up the detection of drug side effects from large health databases.

Keywords:
Graphics Processing Unitadverse drug reactionsdata-driven approachsignal detection

More Related Videos

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.2K
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

18.4K

Related Experiment Videos

Last Updated: Sep 22, 2025

Microfluidic Imaging Flow Cytometry by Asymmetric-detection Time-stretch Optical Microscopy ATOM
07:19

Microfluidic Imaging Flow Cytometry by Asymmetric-detection Time-stretch Optical Microscopy ATOM

Published on: June 28, 2017

10.4K
Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.2K
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

18.4K

Area of Science:

  • Pharmacovigilance and Pharmacoepidemiology
  • Computational Health Sciences
  • Public Health

Background:

  • Adverse drug reactions (ADRs) pose a significant public health challenge.
  • Medico-administrative databases offer valuable real-world data for pharmacovigilance.
  • The Weighted Cumulative Exposure (WCE) statistical model identifies temporal links between drug prescriptions and adverse events.

Purpose of the Study:

  • To implement the WCE statistical model using Graphics Processing Unit (GPU) programming.
  • To accelerate the computational time of the WCE model for analyzing large medico-administrative databases.
  • To enhance the detection of adverse drug reaction spectra.

Main Methods:

  • Pre-processing of care pathways using the Python Pandas library.
  • Calculation of temporal co-variables with the Python KeOps library.
  • Estimation of model parameters utilizing the Python PyTorch library for deep learning.

Main Results:

  • GPU implementation accelerated the WCE method by 1,000x on a graphics card and up to 10,000x on a GPU server.
  • This optimization overcomes the computational time limitations of the original WCE model.
  • Enables the study of ADRs for all marketed drugs using large-scale databases.

Conclusions:

  • GPU programming provides a significant speed-up for the WCE statistical model.
  • This enhanced WCE model facilitates comprehensive pharmacovigilance using medico-administrative data.
  • This represents a proof of concept for applying GPU technology in epidemiological research.